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Spotlight on ATSDR: Exposure Investigations
Peter J. Kowalski, MPH, CIH, Barbara A. Anderson, MSEnvE, PE, Susan Moore, MS, and 
Lynn Wilder, PhD, CIH
One way that the Agency for Toxic Substances and Disease Registry (ATSDR) accomplishes 
its mission of serving the public by promoting healthy and safe environments and preventing 
harmful exposures is by investigating and evaluating the potential public health 
consequences of exposures to environmental contamination at a community or site-specific 
level (ATSDR, 2013a). The first step in this process often involves reviewing and analyzing 
existing environmental and exposure-related data to find out whether people have been, are 
being, or may be exposed to environmental contaminants. ATSDR typically relies on 
environmental and exposure-related data provided by state and federal partners. In cases 
where critical data are not available and may not be forthcoming from another agency, 
ATSDR can conduct a site-specific exposure investigation to fill an identified data gap. 
Exposure investigations may include collection of (1) environmental samples of soil, water, 
air, or biota (e.g., fish, crab, fruits, or vegetables that people consume) and/or (2) biological 
samples of a person’s urine or blood that may contain biomarkers suggesting exposure to a 
specific contaminant.
ATSDR uses the following criteria to determine whether a proposed exposure investigation 
is feasible:
• Can an exposed population be identified?
• Does a critical data gap exist that affects our ability to determine if a health 
hazard exists?
• Can an exposure investigation be designed that will address the critical data 
gap?
• Will the results of the exposure investigation affect the public health 
decision(s) for the site?
Additionally, during the planning stages, specific and detailed attention must be given to the 
design of an exposure investigation to ensure that it is grounded in published scientific 
methods. In practical terms, this means that for exposure investigations involving 
environmental sampling, valid sample collection, sample analytical methods, and health-
based comparison values for the environmental media being tested must be available. 
Similarly, for exposure investigations involving biological sampling, appropriate exposure 
biomarker methods and blood or urine reference ranges for the biomarker must be defined.
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ATSDR has completed approximately 250 exposure investigations since the program began 
in 1995; almost half (45%) involved biological sampling and two-thirds (68%) involved 
some type of environmental sampling. The top three most frequently detected contaminants 
at exposure investigation sites were lead (found at 73 sites), arsenic (53 sites), and mercury 
(34 sites) (Figure 1). Those three metals were most often associated with mining or smelting 
operations. The most common volatile organic compounds were benzene-related compounds 
such as benzene, toluene, ethylbenzene, and xylenes, found at 28 sites. Of note, ATSDR 
conducted 20 exposure investigations for hydrogen sulfide in air; 15 exposure investigation 
sites involved polychlorinated biphenyls (PCBs); and 13 exposure investigation sites 
involved dioxins in various sample media.
ATSDR performed exposure investigations in rural, semirural, and urban areas with diverse 
local settings ranging from residential neighborhoods and public parks to municipal landfills 
and commercial oil/gas operations. The number of samples collected during an exposure 
investigation varied depending on site-specific factors such as the exposure pathway, sample 
media, and the number of persons potentially exposed. The number of participants for 
biological exposure investigations has ranged from less than 10 to more than 100 people.
The results of an exposure investigation may inform decisions about prioritization of public 
health actions, changes in policy, the allocation of resources, and the type or extent of 
environmental cleanup activities. In that sense, an exposure investigation can be used to 
support actions of both public health and regulatory agencies. Exposure investigation results 
have prompted changes in state regulations. For example, in Ohio, regulations governing the 
siting of construction and demolition landfills were revised (ATSDR, 2009) and in 
Minnesota, regulations regarding concentrated animal feeding operations were modified 
(Minnesota Department of Health, 2009). Exposure investigations have also led to public 
health actions that directly prevented human exposure. After an exposure investigation in 
South Carolina, public water lines were installed (Orloff et al., 2004) and in Alabama, 
officials began monitoring unregulated contaminants (ATSDR, 2013b). In some cases, 
exposure investigations have led to health studies such as the large-scale evaluation of 
residents living near a former PCB plant in Alabama (Silverstone et al., 2012).
An exposure investigation is one approach ATSDR can use to better characterize and 
evaluate past, current, and future human exposures to environmental contaminants at a site-
specific level, particularly when such evaluations are constrained by critical data gaps. It is 
important, however, to acknowledge that not all sites are good candidates for this approach. 
Careful consideration of the feasibility and scientific design aspects of an exposure 
investigation are necessary for successful implementation at a site. Over the years, ATSDR 
has developed expertise in conducting a variety of different types of exposure investigations 
(Figure 1) and demonstrated a number of successes in terms of promoting healthy and safe 
environments at the community level.
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FIGURE 1. Top 10 Contaminants, Associated Sample Media, and Site Counts for Agency for 
Toxic Substances and Disease Registry Exposure Investigation Sites, 1995–2013
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